Issuer · CIK 0001806952
LYEL — Lyell Immunopharma, Inc.
Recent filings
- Jul 28, 2026·Form 4·Other—
LYEL/Lyell Immunopharma, Inc.
Innovative Cellular Therapeutics Holdings Ltd · 10pct_owner
Mechanical filing
AI thesis skipped - Jul 27, 2026·Form 4·Other—
LYEL/Lyell Immunopharma, Inc.
Innovative Cellular Therapeutics Holdings Ltd · 10pct_owner
Mechanical filing
AI thesis skipped - Jul 20, 2026·Form 4·Sell$137
LYEL/Lyell Immunopharma, Inc.
Innovative Cellular Therapeutics Holdings Ltd · 10pct_owner
Mechanical filing
AI thesis skipped - Jul 18, 2026·Form 4·Sell$137.3
LYEL/Lyell Immunopharma, Inc.
Innovative Cellular Therapeutics Holdings Ltd · 10pct_owner
Mechanical filing
AI thesis skipped - Jul 1, 2026·Form 4·Other—
LYEL/Lyell Immunopharma, Inc.
Innovative Cellular Therapeutics Holdings Ltd · 10pct_owner
Mechanical filing
AI thesis skipped - Jun 19, 2026·Form 4·Other—
LYEL/Lyell Immunopharma, Inc.
Innovative Cellular Therapeutics Holdings Ltd · 10pct_owner
Mechanical filing
AI thesis skipped - Jun 15, 2026·Form 4·Sell$7.3K
LYEL/Lyell Immunopharma, Inc.
Seely Lynn · director
Mechanical filing
AI thesis skipped - Jun 15, 2026·Form 4·Sell$2.5K
LYEL/Lyell Immunopharma, Inc.
Lee Gary K. · Chief Scientific Officer
Mechanical filing
AI thesis skipped - Jun 15, 2026·Form 4·Sell$1.7K
LYEL/Lyell Immunopharma, Inc.
Hill Stephen J. · Chief Operating Officer
Mechanical filing
AI thesis skipped - Jun 15, 2026·Form 4·Sell$4.1K
LYEL/Lyell Immunopharma, Inc.
Bulis Veronica Sanchez · VP, Corporate Controller
Mechanical filing
AI thesis skipped - Jun 12, 2026·Form 4·Other—
LYEL/Lyell Immunopharma, Inc.
RIEFLIN WILLIAM JL · director
Mechanical filing
AI thesis skipped - Jun 12, 2026·Form 4·Other—
LYEL/Lyell Immunopharma, Inc.
Ramachandra Sumant · director
Mechanical filing
AI thesis skipped - Jun 12, 2026·Form 4·Other—
LYEL/Lyell Immunopharma, Inc.
Klausner Richard · director
Mechanical filing
AI thesis skipped - Jun 12, 2026·Form 4·Other—
LYEL/Lyell Immunopharma, Inc.
FRIEDMAN CATHY · director
Mechanical filing
AI thesis skipped - Jun 12, 2026·Form 4·Other—
LYEL/Lyell Immunopharma, Inc.
BRAWLEY OTIS W · director
Mechanical filing
AI thesis skipped - Jun 11, 2026·Form 4·Sell$25K
LYEL/Lyell Immunopharma, Inc.
Shook David · Chief Medical Officer
Mechanical filing
AI thesis skipped